Leadership Evidence

Healthcare Interoperability Product Case Studies

Anonymized examples of product problems, affected users, competing priorities, rejected alternatives, execution models, and observed operational change.

Case Study

Health system with inpatient and ambulatory workflows, multiple technical owners, and mixed legacy-to-modern interoperability priorities.

Health System Interface Modernization

Product Context and Affected Users

A large health system needed product, clinical, implementation, and support teams to align legacy lab and order interfaces with a more modern interoperability roadmap across inpatient and ambulatory workflows.

Product Problem

Affected implementation and clinical users were navigating site-specific mapping conventions and uneven launch criteria. Product and delivery teams could not compare readiness consistently, which created rework and slowed decisions.

Constraints and Competing Priorities

  • Inpatient and ambulatory workflows needed to stay aligned without destabilizing existing production interface behavior.
  • Technical leads, QA, operations, and clinical stakeholders each controlled a different part of readiness evidence.
  • Legacy HL7 and interface-engine realities still had to work while the organization pushed toward more modern interoperability patterns.

Decision and Rejected Alternative

Standardized mapping expectations, readiness checkpoints, and launch evidence across workstreams. The rejected alternative was to preserve site-by-site criteria for maximum local flexibility; that would have continued inconsistent decisions and shifted avoidable complexity into QA and support.

Execution Model

  • Facilitated discovery workshops to align technical and clinical handoff expectations.
  • Standardized mapping requirements and acceptance criteria for HL7 v2 and FHIR-related workstreams.
  • Established recurring readiness reviews with shared risk ownership across product, engineering, QA, and operations.
  • Introduced a cutover checklist model that clarified dependencies before launch approval.

Specific Before and After

  • Before, each workstream assembled readiness evidence differently; after, teams reviewed the same mapping, dependency, and launch criteria.
  • Before, mapping ambiguity surfaced late in testing; after, expectations were resolved earlier through shared acceptance criteria.
  • Go or no-go discussions moved from competing status narratives to explicit evidence and named risk ownership.

Interoperability Product Relevance

Shows product leadership that converts recurring implementation variation into a reusable platform operating model without ignoring clinical workflow constraints.

Standards and Tooling

HL7 v2FHIR R4Interface enginesJira

Case Study

National program with compressed rollout windows, HL7 orders/results coordination, and high operational visibility.

National Lab Program Onboarding

Product Context and Affected Users

A national lab program needed institution users, implementation teams, operations, and support to onboard remote testing workflows under compressed timelines and strict data-integrity expectations.

Product Problem

Rapid onboarding demand encouraged local workarounds and inconsistent validation, pushing repeated product and workflow issues into early-life support when users needed stability most.

Constraints and Competing Priorities

  • Rollouts were happening under compressed timelines with limited room for coordination gaps.
  • Message handling, testing, and issue ownership had to hold up under high operational visibility.
  • Engineering, QA, implementation, operations, and delivery leadership all needed the same view of readiness and escalation.

Decision and Rejected Alternative

Introduced phased onboarding governance with explicit dependency owners, test gates, and hypercare expectations before production promotion. The rejected alternative was to accelerate every institution through a lighter common checklist; that would have hidden integration-specific risk and made launch volume the primary success measure.

Execution Model

  • Built an onboarding governance model with clear ownership for interface, QA, and operations milestones.
  • Implemented integration testing gates to verify message handling before production release.
  • Defined hypercare response workflows with escalation paths for high-priority defects.
  • Consolidated status reporting so leaders could see risk, readiness, and issue trends in one view.

Specific Before and After

  • Before, recurring validation gaps appeared during early-life support; after, those checks and owners were visible before production promotion.
  • Before, readiness and escalation status lived across team-specific reporting; after, leaders and delivery teams used a shared view of risk and ownership.
  • Launch planning and hypercare became one operating sequence for HL7 orders and results rather than separate handoffs.

Interoperability Product Relevance

Demonstrates product leadership that protects user trust and data integrity when commercial urgency, launch volume, and operational readiness compete.

Standards and Tooling

HL7 v2RabbitMQIntegration testingAzure DevOps

Case Study

Regional rollout spanning both API-based and interface-engine delivery models across hybrid legacy and modern workflows.

Specialty Network FHIR Rollout

Product Context and Affected Users

A regional specialty network needed customer implementation and support users to adopt API-based exchange while maintaining dependable interface-engine workflows for the installed base.

Product Problem

Legacy interfaces and modern APIs were treated as separate delivery models, leaving implementation teams with inconsistent discovery steps and support teams with unclear post-live ownership.

Constraints and Competing Priorities

  • FHIR-based exchange had to coexist with existing interface-engine workflows and support expectations.
  • Implementation and support teams were used to different operating models for legacy interfaces versus modern APIs.
  • Post-live ownership needed to stay clear even as technical standards and integration patterns diversified.

Decision and Rejected Alternative

Defined a shared playbook for discovery, contract review, testing, and post-live ownership across integration models. The rejected alternative was to create a FHIR-only operating path; that would have optimized for the new standard while duplicating governance and leaving installed-base support disconnected.

Execution Model

  • Defined implementation playbooks covering discovery, contract review, testing, and cutover readiness.
  • Aligned FHIR and API acceptance criteria with existing operational support requirements.
  • Coordinated release planning across engineering, QA, and client-facing implementation leads.
  • Established post-live review cadences to prioritize remediation and process updates.

Specific Before and After

  • Before, interface-engine and FHIR work entered delivery through different expectations; after, both followed a shared discovery and readiness model.
  • Before, post-live ownership was clarified during handoff; after, support expectations were part of the product and implementation definition.
  • API-based exchange gained a repeatable path without forcing legacy connectivity into an operating model that did not fit.

Interoperability Product Relevance

Demonstrates platform product judgment: modernize the interoperability portfolio while accounting for migration cost, customer workflow, and ongoing supportability.

Standards and Tooling

FHIR R4SMART on FHIROpenAPIInterface engines